ERCC8 Gene Cockayne Syndrome Type A Genetic Test
At DNA Labs UAE, we offer the ERCC8 Gene Cockayne Syndrome Type A Genetic Test at a cost of AED 4400.0.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Dysmorphology
Doctor and Test Department
This test is performed by our team of expert pediatricians in the Genetics department.
Pre Test Information
Prior to the ERCC8 Gene Cockayne Syndrome Type A Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the ERCC8 Gene Cockayne Syndrome Type A.
Test Details
The ERCC8 gene, also known as Excision Repair Cross-Complementation Group 8, is associated with Cockayne Syndrome Type A (CSA). CSA is a rare genetic disorder characterized by symptoms such as growth failure, intellectual disability, hearing loss, and premature aging.
NGS (Next-Generation Sequencing) genetic testing is utilized to analyze multiple genes simultaneously. In the case of the ERCC8 gene and CSA, NGS genetic testing can identify mutations or variants in the ERCC8 gene that may be responsible for the development of CSA in an individual.
The NGS genetic test for the ERCC8 gene and CSA involves obtaining a DNA sample, usually through a blood sample or cheek swab, and analyzing the DNA for any mutations or variants in the ERCC8 gene. This test is beneficial in confirming a diagnosis of CSA in individuals with suspected symptoms and can also be used for carrier testing in individuals with a family history of CSA.
It is crucial to note that genetic testing should always be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support.
Test Name | ERCC8 Gene Cockayne syndrome type A Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Dysmorphology |
Doctor | Pediatrics |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for ERCC8 Gene Cockayne syndrome type A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ERCC8 Gene Cockayne syndrome type A NGS Genetic DNA Test gene ERCC8 |
Test Details |
ERCC8 gene, also known as Excision Repair Cross-Complementation Group 8, is associated with Cockayne syndrome type A (CSA). CSA is a rare genetic disorder characterized by a variety of symptoms including growth failure, intellectual disability, hearing loss, and premature aging. NGS (Next-Generation Sequencing) genetic testing refers to a high-throughput sequencing technology that can analyze multiple genes simultaneously. In the context of ERCC8 gene and CSA, NGS genetic testing can identify mutations or variants in the ERCC8 gene that may be responsible for the development of CSA in an individual. The NGS genetic test for ERCC8 gene and CSA involves obtaining a DNA sample, usually through a blood sample or cheek swab, and analyzing the DNA for any mutations or variants in the ERCC8 gene. This test can help confirm a diagnosis of CSA in individuals with suspected symptoms and can also be used for carrier testing in individuals with a family history of CSA. It is important to note that genetic testing should always be conducted under the guidance of a healthcare professional or genetic counselor who can interpret the results and provide appropriate counseling and support. |